These agents markedly induced the expression of circASCC3 and its host gene ASCC3, as well as the p53 target gene p21 in a panel of wild-type (WT) p53-harboring cancer cells (Fig. 2 A–D and SI Appendix, Fig. S2A). The gene discussed is ASCC3; the disease is cancer.